# Association Between Drug-related Cutaneous Adverse Events and Progression Free Survival in Patients Treated with Enfortumab Vedotin

> **NCT06682845** · — · COMPLETED · sponsor: **Hospices Civils de Lyon** · enrollment: 22 (actual)

## Conditions studied

- Cutaneous Adverse

## Interventions

- **OTHER:** Collection of data in patients' medical files

## Key facts

- **NCT ID:** NCT06682845
- **Lead sponsor:** Hospices Civils de Lyon
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2024-05-02
- **Primary completion:** 2024-05-02
- **Final completion:** 2024-06-30
- **Target enrollment:** 22 (ACTUAL)
- **Last updated:** 2024-11-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06682845

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06682845, "Association Between Drug-related Cutaneous Adverse Events and Progression Free Survival in Patients Treated with Enfortumab Vedotin". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT06682845. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*